# Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine

> **NCT01758185** · PHASE4 · COMPLETED · sponsor: **Beijing Center for Disease Control and Prevention** · enrollment: 3308 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** recombinant hepatitis b vaccine
- **BIOLOGICAL:** Aleph influenza vaccine

## Key facts

- **NCT ID:** NCT01758185
- **Lead sponsor:** Beijing Center for Disease Control and Prevention
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-11
- **Final completion:** 2012-12
- **Target enrollment:** 3308 (ACTUAL)
- **Last updated:** 2013-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01758185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01758185, "Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01758185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*